Board Meeting17 Jul 2026, 01:20 pm
Dr. Lal PathLabs Board Meeting on July 24 to Consider Q1 Results & Interim Dividend
AI Summary
Dr. Lal PathLabs Ltd has announced that its Board of Directors will convene on July 24, 2026. The primary agenda items include the consideration and approval of the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the Board will evaluate the possibility of declaring an interim dividend for the Financial Year 2026-27. This meeting follows up on a previous intimation dated June 29, 2026.
Key Highlights
- Board meeting scheduled for July 24, 2026.
- To consider Q1 FY27 un-audited financial results.
- Potential interim dividend for FY27 to be discussed.
- Confirms earlier intimation regarding the board meeting date.
Price Impact
More from LALPATHLAB